NuCana (NCNA) Competitors $0.05 0.00 (-8.57%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$0.05 +0.00 (+1.53%) As of 07/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NCNA vs. CWBR, EVFM, NMTR, ATXI, PTPI, TRVN, HEPA, PBLA, SYRS, and SRNEShould you be buying NuCana stock or one of its competitors? The main competitors of NuCana include CohBar (CWBR), Evofem Biosciences (EVFM), 9 Meters Biopharma (NMTR), Avenue Therapeutics (ATXI), Petros Pharmaceuticals (PTPI), Trevena (TRVN), Hepion Pharmaceuticals (HEPA), Panbela Therapeutics (PBLA), Syros Pharmaceuticals (SYRS), and Sorrento Therapeutics (SRNE). These companies are all part of the "pharmaceutical products" industry. NuCana vs. Its Competitors CohBar Evofem Biosciences 9 Meters Biopharma Avenue Therapeutics Petros Pharmaceuticals Trevena Hepion Pharmaceuticals Panbela Therapeutics Syros Pharmaceuticals Sorrento Therapeutics CohBar (NASDAQ:CWBR) and NuCana (NASDAQ:NCNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment. Which has stronger valuation & earnings, CWBR or NCNA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCohBarN/AN/A-$12.18MN/AN/ANuCanaN/AN/A-$24.28M-$7.02-0.01 Is CWBR or NCNA more profitable? CohBar's return on equity of 0.00% beat NuCana's return on equity.Company Net Margins Return on Equity Return on Assets CohBarN/A N/A N/A NuCana N/A -319.85%-88.55% Does the media prefer CWBR or NCNA? In the previous week, NuCana had 5 more articles in the media than CohBar. MarketBeat recorded 5 mentions for NuCana and 0 mentions for CohBar. NuCana's average media sentiment score of 0.21 beat CohBar's score of 0.00 indicating that NuCana is being referred to more favorably in the news media. Company Overall Sentiment CohBar Neutral NuCana Neutral Do analysts prefer CWBR or NCNA? NuCana has a consensus target price of $25.00, suggesting a potential upside of 54,366.23%. Given NuCana's stronger consensus rating and higher probable upside, analysts clearly believe NuCana is more favorable than CohBar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CohBar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NuCana 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility and risk, CWBR or NCNA? CohBar has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, NuCana has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Do insiders and institutionals hold more shares of CWBR or NCNA? 2.5% of CohBar shares are owned by institutional investors. Comparatively, 44.0% of NuCana shares are owned by institutional investors. 6.5% of CohBar shares are owned by insiders. Comparatively, 31.2% of NuCana shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryNuCana beats CohBar on 8 of the 11 factors compared between the two stocks. Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NCNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCNA vs. The Competition Export to ExcelMetricNuCanaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$279K$2.95B$5.54B$9.14BDividend YieldN/A2.43%5.01%4.00%P/E Ratio-0.0121.1628.6919.45Price / SalesN/A184.72373.1779.78Price / CashN/A41.0524.7227.47Price / Book0.037.758.255.58Net Income-$24.28M-$55.05M$3.19B$252.81M7 Day PerformanceN/A9.69%3.53%2.11%1 Month PerformanceN/A13.80%9.56%11.87%1 Year PerformanceN/A3.55%30.54%16.61% NuCana Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCNANuCana3.2241 of 5 stars$0.05-8.6%$25.00+54,366.2%-98.5%$279KN/A-0.0130Stock SplitHigh Trading VolumeCWBRCohBarN/A$0.41flatN/AN/A$1.19MN/A0.0010EVFMEvofem Biosciences1.3618 of 5 stars$0.01-1.0%N/A-14.8%$1.18M$11.39M-0.02120NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220ATXIAvenue Therapeutics2.0239 of 5 stars$0.32-6.2%N/A-88.5%$1.02MN/A0.024Trending NewsPTPIPetros Pharmaceuticals0.5715 of 5 stars$0.03-8.9%N/A-99.8%$991K$5.11M-0.0120TRVNTrevena1.7168 of 5 stars$0.91-3.2%$5.00+449.5%-84.9%$873K$443K-0.0240HEPAHepion Pharmaceuticals0.2668 of 5 stars$0.07+6.7%N/A-99.9%$787KN/A-0.0220Gap DownPBLAPanbela Therapeutics0.2146 of 5 stars$0.16-1.5%N/A-32.8%$765KN/A0.006Gap UpSYRSSyros Pharmaceuticals4.1529 of 5 stars$0.03+11.6%$3.33+11,804.8%-99.5%$751K$386K-0.01120SRNESorrento Therapeutics0.3685 of 5 stars$0.00-7.1%N/A-86.5%$717K$60.32M0.00800Gap Down Related Companies and Tools Related Companies CohBar Competitors Evofem Biosciences Competitors 9 Meters Biopharma Competitors Avenue Therapeutics Competitors Petros Pharmaceuticals Competitors Trevena Competitors Hepion Pharmaceuticals Competitors Panbela Therapeutics Competitors Syros Pharmaceuticals Competitors Sorrento Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NCNA) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NCNA Stock Alerts